Abstract:ABSTRACT Fungal infections are a major contributor to morbidity and mortality among immunocompromised populations. Moreover, fungal disease caused by molds are difficult to treat and are associated with particularly high mortality. To address the need for new mold-active antifungal drugs, we performed a high-throughput screen with Aspergillus fumigatus , the most common pathogenic mold. We identified a novel, pyrimidine-based chemical scaffold with broad-spectrum antifungal activity including activity against several difficult-to-treat molds. A chemical genetics screen of Saccharomyces cerevisiae suggested that this compound may target the endoplasmic reticulum (ER) and perturb ER function and/or homeostasis. Consistent with this model, this compound induces the unfolded protein response and inhibits secretion of A. fumigatus collagenases. Initial cytotoxicity and pharmacokinetic studies show favorable features including limited mammalian cell toxicity and bioavailability in vivo . Together, these data support the further medicinal chemistry and pre-clinical development of this pyrimidine scaffold toward more effective treatments for life-threatening invasive mold infections. IMPORTANCE Invasive fungal diseases are life-threatening infections caused by fungi in immunocompromised individuals. Currently, there are only three major classes of antifungal drugs available to treat fungal infections; however, these options are becoming even more limited with the global emergence of antifungal drug resistance. To address the need for new antifungal therapies, we performed a screen of chemical compounds and identified a novel molecule with antifungal activity. Initial characterization of this compound shows drug-like features and broad-spectrum activity against medically important fungi. Together, our results support the continued development of this compound as a potential future therapy for these devastating fungal infections.

Targeting Fungal Virulence Factor by Small Molecules: Structure-based Discovery of Novel Secreted Aspartic Protease 2 (SAP2) Inhibitors.

Novel non-peptidic small molecule inhibitors of secreted aspartic protease 2 (SAP2) for the treatment of resistant fungal infections.

Secreted Aspartyl Proteinase:A Novel Antifungal Target

Revealing anti-fungal potential of plant-derived bioactive therapeutics in targeting secreted aspartyl proteinase (SAP) of Candida albicans: a molecular dynamics approach

Construction and activity evaluation of novel dual-target (SE/CYP51) anti-fungal agents containing amide naphthyl structure

Anticandidal Effect of New Imidazole Derivatives Over Aspartic Protease Inhibition

Molecular Detection of Secreted Aspartyl Proteinases (Saps) From Dental Isolates of Candida albicans and Targeting With Psidium guajava Biocompounds: An In Vitro and In Silico Analysis

Discovery of Simplified Sampangine Derivatives As Novel Fungal Biofilm Inhibitors.

Targeting virulence: A new paradigm for antifungals

Targeting Fructosamine Oxidase (Amadoriase II) in Aspergillus fumigatus: Comprehensive Virtual Screening, ADMET Analysis, and Molecular Dynamics Simulation of Triazole Derivatives

A series of pyrimidine-based antifungals with anti-mold activity disrupt ER function in Aspergillus fumigatus

A Dual-Targeting Antifungal is Effective Against Multidrug-Resistant Human Fungal Pathogens

Re-emerging Aspartic Protease Targets: Examining Cryptococcus neoformans Major Aspartyl Peptidase 1 as a Target for Antifungal Drug Discovery

Secreted Aspartyl Proteinases Targeted Multi-Epitope Vaccine Design for Candida dubliniensis Using Immunoinformatics

Discovery of a New Chemical Scaffold for the Treatment of Superbug Candida Auris Infections

A Screening Assay Based on Host-Pathogen Interaction Models Identifies a Set of Novel Antifungal Benzimidazole Derivatives

Design, Synthesis, and Structure-Activity Relationship Studies of Novel Triazole Agents with Strong Antifungal Activity Against Aspergillus Fumigatus

Design, synthesis, and antifungal activity evaluation of novel 2-cyano-5-oxopentanoic acid derivatives as potential succinate dehydrogenase inhibitors

Design and testing of selective inactivators against an antifungal enzyme target

Scaffold Hopping of Sampangine: Discovery of Potent Antifungal Lead Compound Against Aspergillus Fumigatus and Cryptococcus Neoformans.

Aspergillus flavus squalene synthase as an antifungal target: Expression, activity, and inhibition.